These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 1865631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
    van Gilst WH, Tio RA, van Wijngaarden J, de Graeff PA, Wesseling H.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early ACE-inhibition in myocardial infarction. Possible role of bradykinin.
    van Gilst WH, de Graeff PA.
    Agents Actions Suppl; 1992; 38 ( Pt 3)():80-9. PubMed ID: 1462886
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB.
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [Abstract] [Full Text] [Related]

  • 8. The effects of angiotensin-converting enzyme inhibition on coronary blood flow and infarct size limitation.
    Dargie HJ, Ray SG.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():101-6. PubMed ID: 2674435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of ACE inhibition on neurohormones.
    Remme WJ.
    Eur Heart J; 1998 Sep; 19 Suppl J():J16-23. PubMed ID: 9796836
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prevention with angiotensin-converting enzyme (ACE) inhibitors].
    Ertl G, Gaudron P, Neubauer S, Bauer B.
    Z Kardiol; 1992 Sep; 81 Suppl 4():205-10. PubMed ID: 1290300
    [Abstract] [Full Text] [Related]

  • 14. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India.
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A, Richardt G, Kurz T.
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.